Patents by Inventor Nina Costantino

Nina Costantino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9371532
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: June 21, 2016
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Publication number: 20140377809
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 8859277
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: October 14, 2014
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Publication number: 20130280811
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 24, 2013
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Publication number: 20100136692
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: January 15, 2010
    Publication date: June 3, 2010
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 7674621
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: March 9, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 7521242
    Abstract: Methods are disclosed herein for inducing homologous recombination in a host cell comprising a target nucleic acid, using a single-stranded nucleic acid molecule. The single-stranded nucleic acid molecule has a sufficient number of nucleotides homologous to the target nucleic acid to enable homologous recombination with the target nucleic acid. The host cell includes a de-repressible promoter operably linked to a nucleic acid encoding a single-stranded binding protein and is deficient for mismatch repair. Isolated host cells of use in this method are also disclosed.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 21, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Donald L. Court, Xin-tian Li, Jian-Dong Huang, Nina Costantino, Depei Liu
  • Publication number: 20050273869
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: May 20, 2005
    Publication date: December 8, 2005
    Inventors: Donald Court, Simanti Datta, Nina Costantino
  • Publication number: 20050079618
    Abstract: Methods are disclosed herein for inducing homologous recombination in a host cell comprising a target nucleic acid, using a single-stranded nucleic acid molecule. The single-stranded nucleic acid molecule has a sufficient number of nucleotides homologous to the target nucleic acid to enable homologous recombination with the target nucleic acid. The host cell includes a de-repressible promoter operably linked to a nucleic acid encoding a single-stranded binding protein and is deficient for mismatch repair. Isolated host cells of use in this method are also disclosed.
    Type: Application
    Filed: May 7, 2004
    Publication date: April 14, 2005
    Inventors: Donald Court, Xin-tian Li, Jian-Dong Huang, Nina Costantino, Depei Liu